Dynavax and Mount Sinai Announce Collaboration to Develop a Universal Influenza Vaccine Candidate with CpG 1018 Adjuvant

Ads

You May Also Like

FIT Biotech Oy: EHVA clinical trial authorization granted for testing FIT-06 in UK

FIT Biotech Oy                                                             Company release 26.6.2018 at 8:30 AM EET EHVA clinical trial authorization ...